Several sexually transmitted infections spread efficiently through blood, and in some cases the per-exposure risk from a contaminated blood transfusion dwarfs the risk from sexual contact. HIV, hepatitis B, hepatitis C, and HTLV are the best-established examples, but the line between “sexually transmitted” and “bloodborne” is blurrier than most people assume. Understanding which STDs carry blood-transmission risk matters for anyone who receives transfusions, works in healthcare, shares injection equipment, or simply wants to know what modern blood-safety measures actually protect against.
Which STDs Spread Through Blood
The infections most commonly described as both sexually transmitted and bloodborne fall into a short list of viruses. HIV is the most widely recognized. Hepatitis B virus (HBV) and hepatitis C virus (HCV) are sometimes left out of “STD” conversations because they are so closely associated with contaminated needles and transfusions, but both also spread through sexual contact, and HBV does so fairly readily. Human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) round out the group: they infect white blood cells and can pass through transfusions, shared needles, breastfeeding, and sexual intercourse.
What makes these four viruses particularly dangerous in a blood-transmission context is that they can circulate in the bloodstream for weeks or months before a person shows symptoms or tests positive on standard antibody screens. That silent window is the reason blood banks invest heavily in molecular testing rather than relying on antibody detection alone.
How Blood Exposure Compares to Sexual Exposure
The difference in transmission efficiency between blood contact and sexual contact is striking. A systematic review of per-act HIV transmission risk found that a contaminated blood transfusion carried an estimated risk of about 93 per 100 exposures, compared with roughly 1.4 per 100 for receptive anal intercourse and less than 0.1 per 100 for receptive vaginal intercourse.1PubMed Central. Estimating per-act HIV transmission risk: a systematic review In practical terms, receiving a unit of HIV-contaminated blood almost guarantees infection, while a single unprotected sexual encounter carries far lower odds. A separate meta-analysis found that infectivity from confirmed contaminated blood transfusions ranged from about 88 to 100 percent, with a weighted average around 93 percent.2AIDS. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis
Needle-sharing during injection drug use falls somewhere in between. The same systematic review estimated the per-act risk of HIV from sharing a needle at about 0.63 percent, while needlestick injuries in healthcare settings averaged around 0.23 percent.2AIDS. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis These figures help explain why injection drug use has been such a powerful driver of HIV and hepatitis C epidemics: even though any single shared needle is less efficient than a full blood transfusion, frequent sharing accumulates risk quickly.
For hepatitis B, the picture is shaped by viral load. Whether a needlestick or a transfusion actually leads to infection depends heavily on how much virus is in the source blood. Research on healthcare-worker-to-patient HBV transmission found that the blood of transmitting individuals contained viral DNA levels that were sometimes extremely high, and that transmission by needlestick became unlikely when viral loads fell below a certain threshold.3PubMed. Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions That makes HBV somewhat unpredictable at the individual level: a person with a high viral load poses far more danger per drop of blood than someone whose infection is well controlled.
Hepatitis C, meanwhile, is acquired primarily through percutaneous blood exposure. A case-control study of blood donors found that most had acquired HCV through direct contact with contaminated blood, though a role for sexual transmission was also suggested.4PubMed. Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study This is why HCV screening is now a standard part of blood donation protocols worldwide.
Shared Needles and Drug Use
Injection drug use remains one of the most significant non-transfusion routes by which STDs spread through blood. The mechanics are straightforward: when a syringe is reused, a small amount of blood from the previous user stays in the barrel and is injected directly into the next person’s bloodstream. For HIV and HCV in particular, this is an extremely efficient mode of transmission.
Research into why people share syringes despite knowing the risks has uncovered a range of reasons, from lack of access to clean equipment to impulsive decisions during withdrawal. Qualitative interviews with people who inject drugs have documented extreme behaviors, including one case where a person drew blood directly from a partner’s vein and injected it into herself, unaware of the infection risk.5PubMed Central. Understanding the Reasons for Sharing Syringes or Needles to Inject Drugs: Conventional Content Analysis While that example is an outlier, it illustrates how blood-to-blood STD transmission can happen outside clinical settings in ways that standard health messaging does not always address.
Syringe exchange programs have been one of the most studied interventions for reducing this type of transmission. An analysis of injection drug users in the early 1990s found that use of a syringe exchange program was independently protective against syringe sharing, alongside HIV testing, counseling, and condom use. Cocaine injection, by contrast, was a predictor for sharing, likely because cocaine’s short duration of action leads to more frequent injections.6JAMA. Syringe and Needle Exchange as HIV/AIDS Prevention for Injection Drug Users
How Safe Is the Modern Blood Supply
If contaminated blood is so efficient at transmitting infections, the natural question is how often that actually happens with today’s screening. The answer, in countries with robust testing programs, is very rarely. But “very rarely” and “never” are not the same thing, and the residual risk comes down to a concept called the window period: the gap between when a donor becomes infected and when current tests can detect the infection.
A landmark study from the mid-1990s estimated the per-unit risk of receiving blood donated during a window period. At that time, the risks were roughly 1 in 493,000 for HIV, 1 in 641,000 for HTLV, 1 in 103,000 for HCV, and 1 in 63,000 for HBV. HBV and HCV together accounted for about 88 percent of the total residual risk.7PubMed. The Risk of Transfusion-Transmitted Viral Infections Those numbers have improved considerably since then, because blood banks have adopted nucleic acid testing (NAT), which detects viral genetic material directly rather than waiting for the body to produce antibodies.
One example of NAT in practice: a Brazilian blood service that replaced older antigen-based HIV screening with a multiplex molecular test screened over 100,000 donations and caught one donation that was HIV-positive by molecular testing but had not yet triggered antibody tests, a yield of roughly 1 in 102,000.8PubMed. Replacement of HIV p24 Ag test by a multiplex RT-PCR method for primary screening of blood donors That single catch represents exactly the kind of window-period infection that older tests would have missed.
Beyond testing, pathogen-reduction technologies add another layer of safety. These methods use chemical or photochemical treatments to inactivate viruses, bacteria, and parasites in donated blood products. They have been applied successfully to plasma-derived products for decades, with no transmission of HIV, HCV, or HBV from US-licensed plasma derivatives since 1987.9PubMed Central. Pathogen-reduction methods: advantages and limits Newer pathogen-reduction technologies are being developed that can also inactivate leukocytes, potentially preventing transfusion-associated graft-versus-host disease alongside infection.10Journal of Umm Al-Qura University for Medical Science. Advances in pathogen reduction technologies: enhancing safety and functionality of blood products
Donor screening questionnaires also play a role. The recent shift in many countries from time-based deferrals (which previously excluded all men who have sex with men for extended periods) to individual risk-based assessments has reshaped how blood services evaluate behavioral risk. Modeling suggests that roughly 1.2 percent of US blood donors would be deferred under this newer individual-risk framework.11PubMed Central. Modeling U.S. Blood Donor Deferrals Under a Policy of Individual Risk Assessment for HIV-Risk Sexual Behavior However, compliance with the new behavior-based questions is imperfect. A study of donors who reported anal sex with a new or more than one partner in the past three months found estimated non-compliance of about 87 percent, meaning most people in that category donated without disclosing the relevant behavior.12PubMed Central. Compliance with gender-neutral sexual behavior-based blood donor screening questions That gap between policy and practice is why laboratory testing remains the primary safeguard, with questionnaires serving as a supplementary filter.
STDs Not Usually Considered Bloodborne
Some sexually transmitted infections are overwhelmingly spread through mucosal or skin-to-skin contact and are not traditionally classified as bloodborne. But emerging research complicates that picture for a few of them.
Herpes simplex virus (HSV) is a good example. HSV is normally transmitted through direct contact with sores or viral shedding from mucosal surfaces, and blood transmission is not considered a meaningful route. However, a study of patients with primary genital herpes found viral DNA in the blood plasma of seven seriously ill patients during their first outbreak. Patients with recurrent herpes, by contrast, showed no detectable virus in the blood. The researchers concluded that blood donors experiencing a primary herpes infection should be deferred, but that recurrent infections probably do not pose a transfusion risk.13PubMed. Detection of herpes simplex virus DNA in plasma of patients with primary but not with recurrent infection: implications for transfusion medicine? Since most blood donors with HSV have long since had their primary infection, this finding is more of a theoretical concern than a practical one.
Human papillomavirus (HPV) presents a more unsettling open question. HPV has always been considered a contact-transmitted virus, spread through skin and mucosal surfaces during sexual activity. But several lines of evidence suggest blood could be an overlooked route. One study found HPV DNA in white blood cells of healthy blood donors, raising the possibility that blood itself could carry the virus.14PubMed. Detection and quantitation of human papillomavirus DNA in peripheral blood mononuclear cells from blood donors Earlier research had also detected HPV DNA in white blood cells collected from clinical samples, suggesting these cells could act as carriers.15PubMed Central. Could human papillomaviruses be spread through blood?
Animal studies have gone further. Experiments in rabbit and mouse models showed that blood infected with papillomavirus could produce infections at distant body sites, complete with detectable viral DNA, RNA, and protein. Researchers even demonstrated that blood from infected mice could transmit the virus to uninfected animals.16PubMed Central. Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models The human blood supply is not screened for HPV, and these findings raise the uncomfortable question of whether it should be. Still, no confirmed cases of human-to-human HPV transmission via transfusion have been documented, so the risk remains hypothetical for now.
Mother-to-Child Transmission Through Blood
Pregnancy and childbirth involve extensive blood exchange between mother and child, and this is a well-documented route for several sexually transmitted viruses. For HIV, mother-to-child transmission accounts for an estimated 15 to 30 percent of cases during pregnancy and delivery, with an additional 5 to 20 percent occurring through breastfeeding.17PubMed Central. Pregnancy and sexually transmitted viral infections Antiretroviral therapy given to the mother during pregnancy and to the infant after birth has dramatically reduced these rates in countries where treatment is accessible, but the underlying biology illustrates how efficiently these viruses move through blood contact.
Hepatitis B is transmitted vertically at particularly high rates when the mother has a high viral load. Without intervention, the risk of a baby acquiring HBV from a highly viremic mother can exceed 90 percent. Vaccination of the newborn within hours of birth, combined with hepatitis B immune globulin, has made this largely preventable. HCV vertical transmission is less common, occurring in roughly 5 to 8 percent of births to infected mothers, and no vaccine or preventive treatment is currently available for it.
Emerging Infections That Cross Both Routes
The traditional categories of “sexually transmitted” and “bloodborne” have always been somewhat arbitrary, and newly emerging infections keep blurring the boundary. Zika virus gained widespread attention during the 2015–2016 epidemic in the Americas. While primarily spread by mosquitoes, Zika was also shown to be sexually transmissible and to pose a real risk through blood transfusion, even in regions with low virus circulation.18PubMed Central. Risk of Zika virus transmission by blood donations in Brazil Blood banks in affected areas implemented molecular screening and post-donation surveillance to reduce the risk.
Ebola virus, typically spread through direct contact with bodily fluids during acute illness, surprised researchers when molecular evidence confirmed sexual transmission from a male survivor to his partner in Liberia in 2015. The genomic analysis showed the virus had persisted in the survivor’s semen for at least 179 days after his symptoms began.19PubMed Central. Molecular Evidence of Sexual Transmission of Ebola Virus While Ebola is not an STD in any conventional sense, this case demonstrated that the distinction between blood-transmitted and sexually transmitted infections is sometimes a matter of circumstance rather than biology. Viruses go where bodily fluids take them.
Tattooing, Piercing, and Informal Settings
Blood-to-blood STD transmission does not require a syringe or a transfusion bag. Any procedure that breaks the skin and involves reusable equipment can theoretically transfer blood between people. Tattooing and body piercing are the most commonly discussed examples, and the evidence for hepatitis C transmission through these routes is instructive.
A critical review of the literature found no definitive evidence that tattoos or piercings received in professional parlors increased the risk of HCV infection. The risk became significant, however, when tattoos were applied in prison settings or by untrained individuals, with adjusted odds ratios in the range of 2.0 to 3.6 among high-risk groups.20PubMed Central. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review The difference comes down to sterilization practices: professional tattoo shops typically use single-use needles and autoclaved equipment, while informal settings may reuse or inadequately clean their tools.
This distinction matters for anyone weighing the risks. Getting a tattoo in a licensed, inspected studio carries minimal bloodborne infection risk. Getting one in an unlicensed setting, from someone who reuses needles or shares ink pots, turns a cosmetic choice into a genuine exposure event. The same logic applies to any informal procedure that pierces the skin, from ear piercing with a shared gun to traditional scarification practices.
Needlestick Injuries in Healthcare
Healthcare workers face occupational exposure to blood-transmitted STDs through needlestick and sharps injuries. These events are common: estimates suggest hundreds of thousands occur annually across hospitals worldwide. The per-exposure risk for HIV from a needlestick is low, averaging around 0.23 percent.2AIDS. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis For hepatitis B, the risk is higher and depends on the source patient’s viral load. Hepatitis C falls somewhere between the two.
Post-exposure protocols have become standardized in most healthcare systems. A review of needlestick injury management documented one case of HCV transmission that was successfully treated, with no other infections transmitted in the study cohort.21PubMed Central. The management of needlestick injuries Post-exposure prophylaxis for HIV, when started within hours of an injury, is highly effective at preventing infection. For HBV, vaccination provides strong protection if the worker has been immunized beforehand. HCV currently lacks both a vaccine and an approved post-exposure prophylaxis, though the availability of highly effective direct-acting antiviral treatments means that even if transmission occurs, the infection can usually be cured.
Organ Transplants and Tissue Donation
Blood transfusion is not the only medical procedure that can transfer blood-transmitted STDs. Organ and tissue transplantation carry their own risks, because transplanted organs contain the donor’s blood and immune cells. Both common infections like HIV and HBV and unexpected pathogens have been transmitted through organ donation, typically recognized when multiple recipients from the same donor develop the same infection. Researchers studying this problem have acknowledged that absolute prevention of donor-derived infections in organ transplantation is not achievable, and that few data exist defining the true incidence of such transmissions or the ideal screening assays to catch them.22PubMed Central. Donor-derived infection–the challenge for transplant safety The urgency of organ transplantation, where recipients may die waiting for a suitable donor, means that some level of calculated risk is inherent to the process.
HTLV is a case where blood product processing offers partial protection. Because HTLV infects white blood cells rather than circulating freely in plasma, filter-based leukoreduction, which removes white blood cells from donated blood, is thought to substantially reduce transmission risk. However, actual laboratory data confirming the effectiveness of this approach against HTLV remain limited.23PubMed Central. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety Whole organs, of course, cannot be leukoreduced, which is one reason transplant recipients face higher transmission risks than blood transfusion recipients for certain pathogens.